Bio Special BioInvest
Brings Total Raised to Over $42 Million Co-Founder of Nexus NeuroTech and Former Verily President of Medical Devices Jordi Parramon Joins as New Boar...
January 12, 2024 | News
Clarametyx Biosciences Inc. (“Clarametyx”), a clinical stage company developing targeted, immune-enabling biologic therapies to counter persist...
January 08, 2024 | News
AstraZeneca has entered into a definitive agreement to acquire Gracell Biotechnologies Inc. (Gracell, NASDAQ: GRCL), a global clinical-stage biopharmaceuti...
December 28, 2023 | News
KarXT Is a Potential First-in-Class Treatment for Schizophrenia and as an Adjunctive Therapy, and First-in-Disease Treatment for Alzheimer’s Di...
December 26, 2023 | News
Poor access to contraceptives presents a significant burden for women living in LMICs. According to a 2022 study, one in 14 women worldwide who want to use...
December 20, 2023 | News
Biorithm, a global women's health medtech, has closed $3.5 million in Series A funding, co-led by Adaptive Capital Partners and SEEDS Capital. Wi...
December 19, 2023 | News
The Japan-based Global Health Innovative Technology Fund (GHIT Fund) announced that it will invest approximately US$3.3 million (approximate...
December 15, 2023 | News
Under the terms of the agreement, Nona Biosciences will receive a total of up to $53 million in upfront and near-term payments, with the potentia...
December 15, 2023 | News
–2023 Gilead Asia Pacific Rainbow Grant Funding Will Support 40 Projects In 2024-2025 To Reduce HIV Stigma And Improve Equity Across Asia Pacific &nd...
November 29, 2023 | News
Before, the publicly listed company at the group level had already secured approximately US$ 60 million in convertible bond financing, which will...
November 21, 2023 | News
Micron has received this grant from the Bill & Melinda Gates Foundation to fund mass production of needle-free vaccines utilizing Micron technology t...
November 20, 2023 | News
Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced the successful completion ...
November 16, 2023 | News
In the Medium-Term ASV Initiatives 2030 Roadmap, announced in February this year, Ajinomoto Co. identified four strategic growth areas including Healthcare...
November 15, 2023 | News
This investment will support Genome Insight’s pursuit of bringing whole-genome based precision diagnostics to routine clinical care. Earlier this yea...
November 03, 2023 | News
Most Read
Bio Jobs
News